Prehabilitation for EOC, Fallopian Tube, Primary Peritoneal Carcinoma and Pancreatic Cancer w/ NACT
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
Beijing Biotech
Imunon
Blue Earth Diagnostics
Avenzo Therapeutics, Inc.
Pfizer
858 Therapeutics, Inc.
PharmaMar
Shanghai Gynecologic Oncology Group
Novakand Pharma AB
Klus Pharma Inc.
Cybrexa Therapeutics
University of Pittsburgh
Pfizer
Salubris Biotherapeutics Inc
Valerio Therapeutics
Elucida Oncology
ImmunoGen, Inc.
University Health Network, Toronto
Fox Chase Cancer Center
Syndax Pharmaceuticals
European Organisation for Research and Treatment of Cancer - EORTC
Pfizer
Corcept Therapeutics
National Cancer Centre, Singapore
National Cancer Centre, Singapore
Gilead Sciences
ImmunoVaccine Technologies, Inc. (IMV Inc.)
National Cheng-Kung University Hospital
National Cancer Institute (NCI)
University of Texas Southwestern Medical Center
MEI Pharma, Inc.
National Cancer Institute (NCI)
University Hospital Heidelberg
Valerio Therapeutics
Vejle Hospital
Rutgers, The State University of New Jersey
National Cancer Institute (NCI)
Roswell Park Cancer Institute
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
University of Kentucky
University of Chicago
National Cancer Institute (NCI)
H. Lee Moffitt Cancer Center and Research Institute
UNC Lineberger Comprehensive Cancer Center
National Institutes of Health Clinical Center (CC)
Garden State Cancer Center at the Center for Molecular Medicine and Immunology
Georgetown University